Nature4 年
Medivir—focusing on cancer one prodrug at a time
The company’s therapeutic strategy consists of designing tumor-directed nucleotide prodrugs. Once taken up by the tumor cells, the nucleotide prodrugs are cleaved, and the nucleotides can ...
来自MSN14 天
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been marked by ...
Nasdaq16 天
FDA Approves ONAPGO Apomorphine Hydrochloride For Parkinson's Disease Treatment
(RTTNews) - Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company, announced on Tuesday the FDA approval of ONAPGO or apomorphine hydrochloride for the treatment of motor fluctuations ...
Yahoo Finance14 天
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride ... subcutaneous infusion therapy combining prodrugs of carbidopa and levodopa, was approved ...
Nasdaq16 天
Supernus Pharmaceuticals Announces FDA Approval of ONAPGO, the First Subcutaneous ...
Supernus Pharmaceuticals has announced the FDA approval of ONAPGO, the first subcutaneous apomorphine infusion device specifically designed to treat motor fluctuations in adults with advanced ...